Efficacy of azithromycin in a real world severe asthma cohort
A. Kumar (Liverpool, United Kingdom), S. Zaidi (Liverpool, United Kingdom), N. Fay (Liverpool, United Kingdom), T. Fitzmaurice (Liverpool, United Kingdom), A. Watkin (Liverpool, United Kingdom), H. Joplin (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom)
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kumar (Liverpool, United Kingdom), S. Zaidi (Liverpool, United Kingdom), N. Fay (Liverpool, United Kingdom), T. Fitzmaurice (Liverpool, United Kingdom), A. Watkin (Liverpool, United Kingdom), H. Joplin (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom). Efficacy of azithromycin in a real world severe asthma cohort. 1107
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: